药品注册申请号:088023
申请类型:ANDA (仿制药申请)
申请人:TEVA
申请人全名:TEVA PHARMACEUTICALS USA INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 ADIPEX-P PHENTERMINE HYDROCHLORIDE CAPSULE;ORAL 37.5MG Yes No AA 1983/08/02 1983/08/02 Discontinued
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2017/05/31 SUPPL-43(补充) Approval Labeling STANDARD
2013/01/07 SUPPL-38(补充) Approval Labeling STANDARD
2012/04/16 SUPPL-37(补充) Approval Labeling
2002/10/15 SUPPL-33(补充) Approval Manufacturing (CMC)
2000/07/07 SUPPL-32(补充) Approval Manufacturing (CMC)
1998/11/12 SUPPL-31(补充) Approval Labeling
1998/03/09 SUPPL-30(补充) Approval Manufacturing (CMC)
1997/12/16 SUPPL-29(补充) Approval Labeling
1997/08/29 SUPPL-28(补充) Approval Labeling
1997/08/29 SUPPL-27(补充) Approval Manufacturing (CMC)
1997/08/29 SUPPL-26(补充) Approval Manufacturing (CMC)
1997/08/29 SUPPL-25(补充) Approval Manufacturing (CMC)
1996/02/13 SUPPL-21(补充) Approval Manufacturing (CMC)
1996/01/25 SUPPL-24(补充) Approval Manufacturing (CMC)
1996/01/25 SUPPL-23(补充) Approval Manufacturing (CMC)
1996/01/25 SUPPL-22(补充) Approval Manufacturing (CMC)
1995/03/02 SUPPL-20(补充) Approval Manufacturing (CMC)
1994/01/26 SUPPL-19(补充) Approval Manufacturing (CMC)
1994/01/26 SUPPL-18(补充) Approval Manufacturing (CMC)
1994/01/26 SUPPL-17(补充) Approval Manufacturing (CMC)
1994/01/26 SUPPL-16(补充) Approval Manufacturing (CMC)
1994/01/26 SUPPL-15(补充) Approval Manufacturing (CMC)
1994/01/26 SUPPL-14(补充) Approval Manufacturing (CMC)
1993/05/25 SUPPL-13(补充) Approval Manufacturing (CMC)
1993/05/25 SUPPL-12(补充) Approval Manufacturing (CMC)
1993/05/25 SUPPL-11(补充) Approval Manufacturing (CMC)
1993/04/01 SUPPL-10(补充) Approval Manufacturing (CMC)
1988/12/23 SUPPL-9(补充) Approval Labeling
1987/11/12 SUPPL-7(补充) Approval Manufacturing (CMC)
1987/11/12 SUPPL-5(补充) Approval Manufacturing (CMC)
1987/11/12 SUPPL-4(补充) Approval Manufacturing (CMC)
1987/11/12 SUPPL-3(补充) Approval Manufacturing (CMC)
1983/12/30 SUPPL-2(补充) Approval Manufacturing (CMC)
1983/11/22 SUPPL-1(补充) Approval Manufacturing (CMC)
1983/08/02 ORIG-1(原始申请) Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:PHENTERMINE HYDROCHLORIDE 剂型/给药途径:CAPSULE;ORAL 规格:37.5MG 治疗等效代码:AA
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
088023 001 ANDA ADIPEX-P PHENTERMINE HYDROCHLORIDE CAPSULE;ORAL 37.5MG Discontinued Yes No AA 1983/08/02 TEVA
040228 001 ANDA PHENTERMINE HYDROCHLORIDE PHENTERMINE HYDROCHLORIDE CAPSULE;ORAL 37.5MG Prescription No No AA 1997/06/19 ELITE LABS INC
040887 001 ANDA PHENTERMINE HYDROCHLORIDE PHENTERMINE HYDROCHLORIDE CAPSULE;ORAL 37.5MG Prescription No No AA 2008/04/24 KVK TECH
201961 001 ANDA PHENTERMINE HYDROCHLORIDE PHENTERMINE HYDROCHLORIDE CAPSULE;ORAL 37.5MG Discontinued No No AA 2011/07/20 LANNETT CO INC
202846 001 ANDA PHENTERMINE HYDROCHLORIDE PHENTERMINE HYDROCHLORIDE CAPSULE;ORAL 37.5MG Discontinued No No AA 2014/02/05 INVAGEN PHARMS
205017 001 ANDA PHENTERMINE HYDROCHLORIDE PHENTERMINE HYDROCHLORIDE CAPSULE;ORAL 37.5MG Prescription No Yes AA 2014/09/25 NUVO PHARM
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database